GE HealthCare reports fourth quarter and full year 2024 financial results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
Go back to GE HealthCare reports fourth quarter and full year 2024 financial results
February 13, 2025 4:30 PM EST
Jefferies analyst Matthew Taylor raised the price target on GE HealthCare (NASDAQ: GEHC) to $110.00 (from $103.00) while maintaining a Buy rating.
The analyst comments "GEHC reported 4Q sales of $5.32B, +2% xfx (+4% ex-China) vs cons $5.32B, & EPS of $1.45 +23% vs cons $1.26. Orders... More
February 13, 2025 2:45 PM EST
Stifel analyst Rick Wise raised the price target on GE HealthCare (NASDAQ: GEHC) to $104.00 (from $102.00) while maintaining a Buy rating.
The analyst comments "Following the GEHC 4Q24 call, we came away feeling encouraged about the companys 4Q24 performance and initial 2025... More
February 13, 2025 2:15 PM EST
Citi analyst Joanne Wuensch raised the price target on GE HealthCare (NASDAQ: GEHC) to $110.00 (from $103.00) while maintaining a Buy rating.
The analyst comments "There was a lot to the 4Q24 against relatively low expectations, with the top-line reflecting continued pressures in China, and... More
February 13, 2025 11:38 AM EST
BTIG analyst Ryan Zimmerman raised the price target on GE HealthCare (NASDAQ: GEHC) to $103.00 (from $99.00) while maintaining a Buy rating.
The analyst comments "We maintain our Buy and raise our PT to $103 (from $99) following GEHC's 4Q24 results. Rev. of $5.319B (2.0% Y/Y, 2.0% Y/Y organic) and adj. EPS of $1.45 (22.9% Y/Y)... More
